These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11819152)

  • 1. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
    Mori K; Yamashita H; Nagao M; Horiguchi J; Yamawaki S
    Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients by K. Mori et al.
    Aleman A
    Pharmacopsychiatry; 2003 Jan; 36(1):43-4; author reply 44. PubMed ID: 12649777
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study.
    Altamura AC; Buccio M; Colombo G; Terzi A; Cazzullo CL
    Encephale; 1986; 12(1):31-6. PubMed ID: 3698889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic use in hospitalised schizophrenic patients in Belgium.
    De Hert M; Wampers M; van Winkel R; Peuskens J
    Psychiatry Res; 2007 Aug; 152(2-3):165-72. PubMed ID: 17445906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing anticholinergic abuse in community mental health.
    Wells BG; Marken PA; Rickman LA; Brown CS; Hamann G; Grimmig J
    J Clin Psychopharmacol; 1989 Dec; 9(6):431-5. PubMed ID: 2592590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse potential of anticholinergics.
    Dose M; Tempel HD
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
    Chamorro García L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma anticholinergic activity and cognitive function in geriatric patients].
    Thienhaus OJ; Thoene J; Allen A; Zemlan FP
    Psychiatr Neurol Med Psychol (Leipz); 1990 May; 42(5):275-81. PubMed ID: 1975100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG
    Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of anticholinergic drugs on attention span and short-term memory skills in children.
    Giramonti KM; Kogan BA; Halpern LF
    Neurourol Urodyn; 2008; 27(4):315-8. PubMed ID: 17828786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.